Superworth

Xenon Pharmaceuticals EPS XENE

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$4.74
Latest quarter, Q2 FY26
−$1.11
Fiscal year 2025
−$4.36

Xenon Pharmaceuticals' earnings per share was −$4.74 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.11.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$4.36n/a
FY2024−$3.02n/a
FY2023−$2.72n/a
FY2022−$2.04n/a
FY2021−$1.76n/a
FY2020−$0.81n/a
FY2019−$1.53n/a
FY2018−$1.61n/a
FY2017−$1.72n/a
FY2016−$1.50n/a
FY2015−$1.25−146%
FY2014$2.69n/a
FY2013n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.11n/a−$4.74
Q1 FY26−$1.17n/a−$4.70
Q4 FY25−$1.31n/a−$4.36
Q3 FY25−$1.15n/a−$3.89
Q2 FY25−$1.07n/a−$3.55
Q1 FY25−$0.83n/a−$3.23
Q4 FY24−$0.84n/a−$3.02
Q3 FY24−$0.81n/a−$2.82
Q2 FY24−$0.75n/a−$2.74
Q1 FY24−$0.62n/a−$2.71
Q4 FY23−$0.64n/a−$2.72
Q3 FY23−$0.73n/a−$2.65

Against its peers

Companies in Drug Manufacturers - General nearest Xenon Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
XENEXenon Pharmaceuticals−$4.74
OGNOrganon$0.77−71% a year
LQDALiquidia$1.39
ARQTArcutis Biotherapeutics$0.22
INDVIndivior Pharmaceuticals$2.78+227% a year
NRIXNurix Therapeutics$2.31
PBHPrestige Consumer Healthcare$3.57−16% a year
HRMYHarmony Biosciences$3.09−0% a year
KNSAKiniksa Pharmaceuticals International$0.97+2325% a year
LGNDLigand Pharmaceuticals$9.40
AMRXAmneal Pharmaceuticals$0.49+4800% a year
Peer median$1.85

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Xenon Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.